NCT07422168

Brief Summary

This study evaluates the safety and effectiveness of hyperbaric oxygen therapy (HBOT) for the treatment of severe radiation-induced complications in patients previously treated with radiotherapy. Patients with clinically significant late radiation injuries will undergo HBOT sessions in a hyperbaric chamber. The study aims to assess clinical improvement of radiation damage and overall treatment tolerance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 19, 2016

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
6.1 years until next milestone

First Submitted

Initial submission to the registry

February 11, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 19, 2026

Completed
Last Updated

February 19, 2026

Status Verified

February 1, 2026

Enrollment Period

3.6 years

First QC Date

February 11, 2026

Last Update Submit

February 18, 2026

Conditions

Keywords

Hyperbaric oxygen therapyHBOT

Outcome Measures

Primary Outcomes (1)

  • Reduction of severe radiation-induced tissue damage

    Clinical Improvement of Radiation-Induced Complications After HBOT

    Up to 3 months after completion of HBOT treatment

Study Arms (1)

Hyperbaric Oxygen Therapy (HBOT)

EXPERIMENTAL

Patients receiving hyperbaric oxygen therapy to treat severe radiation-induced complications and support tissue healing.

Other: Hyperbaric Oxygen Therapy (HBOT)

Interventions

Participants will undergo hyperbaric oxygen therapy sessions in a hyperbaric chamber, breathing 100% oxygen under increased atmospheric pressure, according to institutional protocol, to treat severe radiation-induced complications and support tissue healing.

Hyperbaric Oxygen Therapy (HBOT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (≥18 years)
  • History of radiotherapy
  • Clinically significant radiation-induced complications requiring hyperbaric oxygen therapy
  • Ability to provide written informed consent

You may not qualify if:

  • Contraindications to hyperbaric oxygen therapy (e.g., untreated pneumothorax)
  • Severe comorbidity preventing safe HBOT treatment
  • Inability to tolerate hyperbaric chamber sessions
  • Withdrawal of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Oncology Ljubljana

Ljubljana, 1000, Slovenia

Location

MeSH Terms

Conditions

Radiation Injuries

Interventions

Hyperbaric Oxygenation

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

Oxygen Inhalation TherapyRespiratory TherapyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2026

First Posted

February 19, 2026

Study Start

May 19, 2016

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

February 19, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations